DUBLIN–(BUSINESS WIRE)–The “Needle
Free Drug Delivery Devices Market Size, Share Trends Analysis Report
By Technology, By Application (Vaccine Delivery, Pain Management,
Insulin Delivery, Pediatric Injections), And Segment Forecasts, 2018 –
2024” report has been added to ResearchAndMarkets.com’s
According to AVERT, there were 36.7 million people living with AIDS at
the end of 2016 and 34 million have died due to HIV till date. The
African continent is the most severely affected region, accounting for
70% of the total people infected with HIV worldwide. According to WHO,
around 350 million people have been chronically infected with hepatitis
B. These key factors fuel clinical urgency for adoption of needle free
drug delivery devices.
Based on technology, jet injectors commanded the leading revenue share
of 30% in 2015, owing to associated benefits such as improved dosage
accuracy, better diffusion into tissues, and reduced pain and sharps
The transdermal patch segment is expected to expand at a CAGR of over
10% owing to introduction of technologically advanced products with
associated benefits such as direct drug delivery, ease of use, and
The insulin delivery segment held over 33% of the market in 2015,
which can be attributed to advantages such as self-administration and
availability of wide range of devices such as transdermal patches, jet
injectors, and inhalers
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Needle Free Drug Delivery Devices Industry Outlook
Chapter 4. Needle Free Drug Delivery Devices Technology Outlook
Chapter 5. Needle Free Drug Delivery Devices Application Outlook
Chapter 6. Needle Free Drug Delivery Devices Regional Outlook
Chapter 7. Competitive Landscape
- Antares Pharma Inc.
- Glide Pharmaceutical Technologies Ltd.
- Injex Pharma AG
- Zogenix Inc.
- BioJect Medical Technologies Inc.
- Penjet Corporation
- D’Antonio Consultants International Inc.
- Akra Dermojet
For more information about this report visit https://www.researchandmarkets.com/research/7vzcgr/needle_free_drug?w=4